These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9010218)

  • 21. Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas.
    Gunduz M; Nagatsuka H; Demircan K; Gunduz E; Cengiz B; Ouchida M; Tsujigiwa H; Yamachika E; Fukushima K; Beder L; Hirohata S; Ninomiya Y; Nishizaki K; Shimizu K; Nagai N
    Gene; 2005 Aug; 356():109-17. PubMed ID: 15935570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutated p53 as a molecular marker for the diagnosis of head and neck cancer.
    van Houten VM; Tabor MP; van den Brekel MW; Kummer JA; Denkers F; Dijkstra J; Leemans R; van der Waal I; Snow GB; Brakenhoff RH
    J Pathol; 2002 Dec; 198(4):476-86. PubMed ID: 12434417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck.
    Westra WH; Taube JM; Poeta ML; Begum S; Sidransky D; Koch WM
    Clin Cancer Res; 2008 Jan; 14(2):366-9. PubMed ID: 18223210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
    Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
    Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53 mutations in head and neck cancer: new data and evaluation of mutational spectra.
    Olshan AF; Weissler MC; Pei H; Conway K
    Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):499-504. PubMed ID: 9232336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic instabilities of chromosome 9, 17 and accumulation of p53 overexpression during multistage tumorigesis in head and neck cancer.
    Charuruks N; Shin DM; Voravud N; Ro JY; Hong WK; Hittelman WN
    J Med Assoc Thai; 1996 Dec; 79 Suppl 1():S104-12. PubMed ID: 9071074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients.
    Nathan CO; Amirghahri N; Rice C; Abreo FW; Shi R; Stucker FJ
    Laryngoscope; 2002 Dec; 112(12):2129-40. PubMed ID: 12461330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of apoptosis-related genes in human head and neck squamous cell carcinomas undergoing p53-mediated programmed cell death.
    Frederick MJ; Holton PR; Hudson M; Wang M; Clayman GL
    Clin Cancer Res; 1999 Feb; 5(2):361-9. PubMed ID: 10037186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NF-kappaB gene signatures and p53 mutations in head and neck squamous cell carcinoma.
    Ferris RL; Grandis JR
    Clin Cancer Res; 2007 Oct; 13(19):5663-4. PubMed ID: 17908953
    [No Abstract]   [Full Text] [Related]  

  • 30. Reliable detection of p53 aberrations in squamous cell carcinomas of the head and neck requires transcript analysis of the entire coding region.
    Hauser U; Balz V; Carey TE; Grénman R; Van Lierop A; Scheckenbach K; Bier H
    Head Neck; 2002 Sep; 24(9):868-73. PubMed ID: 12211051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
    Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
    Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Examination of p53 alterations and cytokeratin expression in sputa collected from patients prior to histological diagnosis of squamous cell carcinoma.
    Anderson M; Sladon S; Michels R; Davidson L; Conwell K; Lechner J; Franklin W; Saccomanno G; Wiest J
    J Cell Biochem Suppl; 1996; 25():185-90. PubMed ID: 9027617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance of c-myc and p53 expression in head and neck squamous cell carcinomas.
    Waitzberg AF; Nonogaki S; Nishimoto IN; Kowalski LP; Miguel RE; Brentani RR; Brentani MM
    Cancer Detect Prev; 2004; 28(3):178-86. PubMed ID: 15225897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased expression of p63 in oral lichen planus and graft-vs.-host disease associated with oral inflammation.
    Ebrahimi M; Wahlin YB; Coates PJ; Sjöström B; Nylander K
    J Oral Pathol Med; 2006 Jan; 35(1):46-50. PubMed ID: 16393253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical applications of the diagnosis of p53 alterations in squamous cell carcinoma of the head and neck.
    Lopez-Martinez M; Anzola M; Cuevas N; Aguirre JM; De-Pancorbo M
    Med Oral; 2002; 7(2):108-20. PubMed ID: 11887018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dominant-negative mutations of the tumor suppressor p53 relating to early onset of glioblastoma multiforme.
    Marutani M; Tonoki H; Tada M; Takahashi M; Kashiwazaki H; Hida Y; Hamada J; Asaka M; Moriuchi T
    Cancer Res; 1999 Oct; 59(19):4765-9. PubMed ID: 10519380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrated p53 histopathologic/genetic analysis of premalignant lesions of the esophagus.
    Safatle-Ribeiro AV; Ribeiro U; Sakai P; Clarke MR; Fylyk SN; Ishioka S; Gama-Rodrigues J; Finkelstein SD; Reynolds JC
    Cancer Detect Prev; 2000; 24(1):13-23. PubMed ID: 10757119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p53 mutations in squamous cell carcinoma of the head and neck predominate in a subgroup of former and present smokers with a low frequency of genetic instability.
    Liloglou T; Scholes AG; Spandidos DA; Vaughan ED; Jones AS; Field JK
    Cancer Res; 1997 Sep; 57(18):4070-4. PubMed ID: 9307295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reappraisal of p53 mutations in human malignant astrocytic neoplasms by p53 functional assay: comparison with conventional structural analyses.
    Tada M; Iggo RD; Waridel F; Nozaki M; Matsumoto R; Sawamura Y; Shinohe Y; Ikeda J; Abe H
    Mol Carcinog; 1997 Mar; 18(3):171-6. PubMed ID: 9115587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiation-induced cutaneous carcinoma of the head and neck: is there an early role for p53 mutations?
    Franchi A; Massi D; Gallo O; Santucci M; Porfirio B
    Clin Exp Dermatol; 2006 Nov; 31(6):793-8. PubMed ID: 16824052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.